Gestational age (postmenstrual age in weeks, mean ± standard deviation) |
27.5 ± 4.2 |
0.9230 |
Birth weight (g, mean ± standard deviation) |
1128 ± 839 |
0.6718 |
Bronchopulmonary dysplasia (n) |
34 (60%) |
0.3076 |
Asphyxia (n) |
7 (12%) |
0.4642 |
Intraventricular hemorrhage (all grades) |
16 (28%) |
0.2607 |
Cerebral hemorrhage (intraventricular, cerebellar, n) |
17 (30%) |
0.2782 |
Respiratory distress syndrome (n) |
50 (88%) |
0.7636 |
Maximal grade of respiratory distress syndrome (RDS) |
|
0.4284 |
No RDS (n) |
7 (12%) |
|
Grade 1 (n) |
6 (11%) |
Grade 2 (n) |
18 (32%) |
Grade 3 (n) |
20 (35%) |
Grade 4 (n) |
6 (11%) |
Survival (n) |
49 (86%) |
0.8802 |
Antenatal corticosteroids for lung development (complete, n) |
32 (56%) |
0.9443 |
Maternal infection (n) |
23 (40%) |
0.4403 |
Premature rupture of the membranes (n) |
8 (14%) |
0.2180 |
Small for gestational age (n) |
15 (26%) |
0.4428 |
Number of days with infection (median, range) |
11 (0–80) |
0.7470 |
Retinopathy of prematurity (n) |
34 (60%) |
0.9268 |
Maximal grade of Retinopathy of prematurity (RPM) |
|
0.6947 |
No RPM |
23 (40%) |
|
Stage 1 (n) |
4 (7%) |
Stage 2 (n) |
16 (28%) |
Stage 3 (n) |
14 (25%) |
Stage 4 (n) |
0 |
Stage 5 (n) |
0 |